Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 7, 2020; 26(41): 6442-6454
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6442
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6442
Table 2 Demographic and clinical characteristics of the study patients receiving glycerin enema
Number | IC group (n = 19) | Control (n = 76) | P value |
Age | 70.2 ± 11.7 | 70.2 ± 11.5 | 0.996 |
Sex, male | 8 (42.1%) | 32 (42.1%) | 1.000 |
Initial vital sign | |||
Systolic blood pressure (mmHg, mean ± SD) | 138.5 ± 34.4 | 135.8 ± 27.3 | 0.716 |
Diastolic blood pressure (mmHg, mean ± SD) | 83.6 ± 22.1 | 81.7 ± 16.0 | 0.678 |
Pulse rate | 85.8 ± 22.9 | 84.0 ± 19.4 | 0.727 |
Respiratory rate | 20.6 ± 2.1 | 19.9 ± 2.3 | 0.146 |
Initial symptom | 0.847 | ||
Abdominal pain | 11 (57.9) | 47 (61.8) | |
Constipation | 3 (15.8) | 7 (9.2) | |
Vomiting | 2 (10.5) | 9 (11.8) | |
Miscellaneous symptom | 3 (15.8) | 13 (17.1) | |
Constipation score1 (mean ± SD) | 1.1 ± 1.2 | 0.5 ± 0.8 | 0.022 |
Condition | |||
History of chronic constipation | 8 (42.1) | 17 (22.4) | |
Recurrent usage of enema agent | 3 (15.8) | 7 (9.2) | |
Last defection more than 5 d | 4 (21.1) | 10 (13.2) | |
Failure: Unsuccessful attempts for evacuation before admitting ED | 6 (31.6) | 3 (4.0) | |
ACCI score | |||
mean ± SD | 5.8 ± 3.1 | 4.9 ± 2.3 | 0.245 |
Condition | |||
Myocardial infarction | 2 | 2 | |
Congestive heart failure | 3 | 1 | |
Peripheral vascular disease | 1 | 2 | |
Cerebral vascular disease | 3 | 7 | |
Dementia | 2 | 2 | |
Chronic pulmonary disease | 0 | 1 | |
Connective tissue disease | 0 | 1 | |
Peptic ulcer | 2 | 4 | |
Mild liver disease | 1 | 1 | |
Hemiplegia | 0 | 1 | |
Diabetes | 6 | 15 | |
Moderate or severe renal disease | 3 | 5 | |
Diabetes with end-organ damage | 1 | 3 | |
Solid tumor | 5 | 25 | |
Leukemia | 2 | 1 | |
Lymphoma | 0 | 2 | |
Moderate or severe liver disease | 1 | 2 | |
Metastatic solid tumor | 3 | 11 | |
AIDS | 0 | 0 | |
Drug proposed to predispose to IC | |||
Total No. of patients (moderate + low) | 13 | 57 | 0.560 |
No. of patients taking drugs with moderate evidence | 7 | 39 | 0.259 |
Constipation-inducing drugs | 7 | 39 | |
No. of patients taking drugs with low evidence | 6 | 18 | 0.479 |
Antibiotics | 4 | 12 | |
Chemotherapeutic drugs | 2 | 2 | |
Decongestants | 0 | 1 | |
Diuretics | 1 | 3 | |
Laxative | 3 | 7 | |
Psychotropic drugs | 0 | 6 | |
Initial Laboratory test | |||
CRP (mg/dL) | 5.9 ± 1.0 | 1.4 ± 2.8 | 0.429 |
WBC (× 103/μL) | 13.4 ± 7.5 | 8.4 ± 3.4 | 0.004 |
Plain abdominal radiograph | |||
Abnormal findings | 5 (26.3) | 9 (11.8) | 0.146 |
New symptom after enema | |||
Hematochezia | 11 (57.9) | 0 | |
Abdominal pain | 5 (26.3) | 0 | N/A |
Sudden drop in blood pressure | 3 (15.8) | 0 | |
Asymptomatic | 0 (0.0) | 76 (100.0) | |
Diagnostic tools | N/A | ||
Non contrast-enhanced AP-CT | 1 (5.3) | NA | |
Contrast-enhanced AP-CT | 18 (94.7) | NA | |
Colonoscopy | 14 (73.7) | NA | |
Treatment | N/A | ||
Supported care | 10 (52.6) | NA | |
Surgical resection | 9 (47.4) | NA |
- Citation: Ahn Y, Hong GS, Lee JH, Lee CW, Kim SO. Ischemic colitis after enema administration: Incidence, timing, and clinical features. World J Gastroenterol 2020; 26(41): 6442-6454
- URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6442.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i41.6442